Revelation Biosciences (REVB) Payables (2020 - 2026)
Revelation Biosciences (REVB) posted quarterly Payables of $577501.0 for Q4 2025, down 26.3% year-over-year from $783621.0 in Q4 2024, and down 44.2% quarter-over-quarter from $1.0 million in Q3 2025.
Revelation Biosciences (REVB) Payables (2020 - 2026) Analysis & Trends
Revelation Biosciences (REVB) has reported Payables for 6 consecutive years, with $577501.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Payables fell 26.3% year-over-year to $577501.0; the TTM figure through Dec 2025 stood at $577501.0 (down 26.3% YoY), while the FY2025 annual figure was $577501.0, down 26.3% from the prior year.
- Payables declined to $577501.0 in Q4 2025 per REVB's latest filing, from $1.0 million in the prior quarter.
- Across five years, Payables topped out at $3.7 million in Q3 2021 and bottomed at $466084.0 in Q3 2022.
- Historically, Payables has averaged $1.5 million across 5 years, with a median of $1.1 million in 2023.
- Annual changes were most pronounced in 2021 — Payables soared 2890.02% — and 2022, when it tumbled 87.53%.
- Revelation Biosciences' Payables stood at $3.0 million in 2021, then slumped by 81.44% to $554205.0 in 2022, then surged by 145.38% to $1.4 million in 2023, then tumbled by 42.38% to $783621.0 in 2024, then slipped by 26.3% to $577501.0 in 2025.
- Business Quant data shows REVB's Payables at $577501.0 in Q4 2025, $1.0 million in Q3 2025, and $828894.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Revelation Biosciences | 4.17 Mn | -7.33 Mn | - | 931,093.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 931,093.00 |
| Dec 31, 2025 | 577,501.00 |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 828,894.00 |
| Mar 31, 2025 | 625,058.00 |
| Dec 31, 2024 | 783,621.00 |
| Sep 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 913,866.00 |
| Mar 31, 2023 | 705,089.00 |
| Dec 31, 2022 | 554,205.00 |
| Sep 30, 2022 | 466,084.00 |
| Jun 30, 2022 | 916,475.00 |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 2.99 Mn |
| Sep 30, 2021 | 3.74 Mn |
| Jun 30, 2021 | 3.31 Mn |